title: Executive summary: regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition).
authors.affiliation: Department ofAnesthesiology, Mayo Clinic, Rochester, MN 55905, USA. horlocker.terese@mayo.edu
authors.forename: Terese T
authors.initials: TT
authors.lastname: Horlocker
authors.forename: Denise J
authors.initials: DJ
authors.lastname: Wedel
authors.forename: John C
authors.initials: JC
authors.lastname: Rowlingson
authors.forename: F Kayser
authors.initials: FK
authors.lastname: Enneking
mesh_terms: D000765:Anesthesia, Conduction / Q000379:methods / Q000592:standards*; D000776:Anesthesiology / Q000592:standards; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D012955:Societies, Medical / Q000592:standards; D054556:Venous Thromboembolism / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D006493:Heparin